Followers | 74 |
Posts | 3281 |
Boards Moderated | 0 |
Alias Born | 03/16/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 28, 2018 3:40:36 AM
1. Mandatory Share Conversion:
When I asked my head Equity trader what that would normally mean he answered ‘the only reason is M&A ‘
2. The `Multiple Sources`:
“late stage; parallel negotiations with different unrelated third parties; regarding "substantial alternative potential financings"; "Company anticipates the accounting and disclosure could be impacted by the completion of this process."
3. Ridiculous forward-looking statement
With every caveat possible, this statement was not that of a $100m m/c battered CEO who’s desperate for help who just loaned the company $5m.
4. The DATA:
Or more relevantly the lack of PR over the data. There was only a minimum or PR over data that smashed the previous year’s data.
This lack of PR was not that of a $100m m/c battered CEO who’s desperate for help and who just loaned the company $5m. It’s actually more in line with the actions of a CEO whose been told by a Large Pharma that they want to spread the word on completion of a deal with us.
5. The Comp Share Awards: same as 1, all liabilities that impact the share count have to be out in the open prior to corporate action so the shareholders of the company that buys us have total transparency on the impact of the acquisition.
So, none of what`s been going on are the actions of a beleaguered company with a battered CEO.
I do not hear the echo of ASCO`s ` Please help us ` in anything above.
Lots of other stars are in alignment, none less than the abject failure of other relevant cancer trials and what about the sale of Cognate, we sold it because we don’t need it.
We may get Sawston announcement first which will be good but do not read into that, that with some cash the need of a deal is allayed, because its actually irrelevant the deal is already done.
I was convinced of a Licensing deal but I now think its Buy Out.
Price
Using JUNO & KITE we`d expect $10bn for L, good will for D adds $3bn = $13pps
If we get bought at anything greater than half of that thank your lucky stars because there’s no doubt we were all but history on several occasions.
Do not kid yourself that any sale price below $20bn (PCYC etc) is an outrage, because you`re all amateurs and you will do as amateurs do, which is run losses and cut profits
You will take more money from this from what you may initially think is a cheap price for buyout than you ever would thinking you will hold it once it pops because you wont.
PLEASE NO REPLIES I DON’T CARE WHAT ANYONE THINKS, IM WRITING THIS TO SUPPORT THE GENUINE LONGS AND GENERALLY POSITIVE POSTERS.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM